Networks of Innovation offers an historical perspective on how private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines, and how their activities were related to complex, evolving networks of scientific, governmental, and medical institutions.